FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2022145079> ?p ?o ?g. }

• W2022145079 endingPage "1296" @default.
• W2022145079 startingPage "1288" @default.
• W2022145079 abstract "Cholangiocarcinoma is a fatal tumor with limited therapeutic options. We have reported that calmodulin antagonists tamoxifen and trifluoperazine induced apoptosis in cholangiocarcinoma cells. Here, we determined the effects of tamoxifen on tumorigenesis and the molecular mechanisms of tamoxifen-induced apoptosis.Nude mice xenograft model of cholangiocarcinoma was used and tamoxifen was given i.p. and intratumorally. Cholangiocarcinoma cells were used to characterize molecular mechanisms of tamoxifen-induced apoptosis in vitro.I.p. or intratumoral injection of tamoxifen decreased cholangiocarcinoma tumorigenesis by 40% to 80% in nude mice. In cells isolated from tumor xenografts, tamoxifen inhibited phosphorylation of AKT (pAKT) and cellular FLICE like inhibitory protein (c-FLIP). Immunohistochemical analysis further showed that pAKT was identified in all nontreated tumors but was absent in tamoxifen-treated tumors. In vitro, tamoxifen activated caspase-8 and caspase-10, and their respective inhibitors partially blocked tamoxifen-induced apoptosis. Overexpression of c-FLIP inhibited tamoxifen-induced apoptosis and enhanced tumorigenesis of cholangiocarcinoma cells in nude mice, whereas deletion of the calmodulin-binding domain on c-FLIP restored the sensitivity to tamoxifen and inhibited tumorigenesis. With two additional cholangiocarcinoma cell lines, we confirmed that the expression of FLIP is an important factor in mediating spontaneous and tamoxifen-induced apoptosis.Thus, tamoxifen inhibits cholangiocarcinoma tumorigenesis in nude mice. Tamoxifen-induced apoptosis is partially dependent on caspases, inhibition of pAKT, and FLIP expression. Further, calmodulin-FLIP binding seems to be important in FLIP-mediated resistance to tamoxifen. Therefore, the present studies support the concept that tamoxifen may be used as a therapy for cholangiocarcinoma and possibly other malignancies in which the calmodulin targets AKT and c-FLIP play important roles in the tumor pathogenesis." @default.
• W2022145079 created "2016-06-24" @default.
• W2022145079 creator A5001606544 @default.
• W2022145079 creator A5006353852 @default.
• W2022145079 creator A5010289974 @default.
• W2022145079 creator A5038178209 @default.
• W2022145079 creator A5038955775 @default.
• W2022145079 creator A5044093768 @default.
• W2022145079 creator A5044301848 @default.
• W2022145079 creator A5048965051 @default.
• W2022145079 creator A5063519178 @default.
• W2022145079 date "2009-02-15" @default.
• W2022145079 modified "2023-10-16" @default.
• W2022145079 title "Molecular Mechanisms of Tamoxifen Therapy for Cholangiocarcinoma: Role of Calmodulin" @default.
• W2022145079 cites W1487234933 @default.
• W2022145079 cites W1741559726 @default.
• W2022145079 cites W1966216790 @default.
• W2022145079 cites W1974887744 @default.
• W2022145079 cites W1975155851 @default.
• W2022145079 cites W1976429096 @default.
• W2022145079 cites W1982244071 @default.
• W2022145079 cites W1990332775 @default.
• W2022145079 cites W1995675713 @default.
• W2022145079 cites W2003908597 @default.
• W2022145079 cites W2004078164 @default.
• W2022145079 cites W2009626612 @default.
• W2022145079 cites W2012191233 @default.
• W2022145079 cites W2013519249 @default.
• W2022145079 cites W2020544348 @default.
• W2022145079 cites W2035091743 @default.
• W2022145079 cites W2039048150 @default.
• W2022145079 cites W2042162210 @default.
• W2022145079 cites W2044825593 @default.
• W2022145079 cites W2048620835 @default.
• W2022145079 cites W2050683019 @default.
• W2022145079 cites W2052366943 @default.
• W2022145079 cites W2053442691 @default.
• W2022145079 cites W2054566387 @default.
• W2022145079 cites W2056919940 @default.
• W2022145079 cites W2059996601 @default.
• W2022145079 cites W2064862565 @default.
• W2022145079 cites W2066834207 @default.
• W2022145079 cites W2076355885 @default.
• W2022145079 cites W2078797029 @default.
• W2022145079 cites W2084344997 @default.
• W2022145079 cites W2089525900 @default.
• W2022145079 cites W2099070047 @default.
• W2022145079 cites W2103002807 @default.
• W2022145079 cites W2119812397 @default.
• W2022145079 cites W2120385383 @default.
• W2022145079 cites W2121232458 @default.
• W2022145079 cites W2141349182 @default.
• W2022145079 cites W2148994831 @default.
• W2022145079 cites W2154256241 @default.
• W2022145079 cites W2155200468 @default.
• W2022145079 cites W2169932535 @default.
• W2022145079 cites W4238567307 @default.
• W2022145079 cites W91452638 @default.
• W2022145079 doi "https://doi.org/10.1158/1078-0432.ccr-08-1150" @default.
• W2022145079 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/2905314" @default.
• W2022145079 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19228732" @default.
• W2022145079 hasPublicationYear "2009" @default.
• W2022145079 type Work @default.
• W2022145079 sameAs 2022145079 @default.
• W2022145079 citedByCount "45" @default.
• W2022145079 countsByYear W20221450792012 @default.
• W2022145079 countsByYear W20221450792013 @default.
• W2022145079 countsByYear W20221450792014 @default.
• W2022145079 countsByYear W20221450792015 @default.
• W2022145079 countsByYear W20221450792016 @default.
• W2022145079 countsByYear W20221450792017 @default.
• W2022145079 countsByYear W20221450792018 @default.
• W2022145079 countsByYear W20221450792019 @default.
• W2022145079 countsByYear W20221450792020 @default.
• W2022145079 countsByYear W20221450792021 @default.
• W2022145079 countsByYear W20221450792022 @default.
• W2022145079 countsByYear W20221450792023 @default.
• W2022145079 crossrefType "journal-article" @default.
• W2022145079 hasAuthorship W2022145079A5001606544 @default.
• W2022145079 hasAuthorship W2022145079A5006353852 @default.
• W2022145079 hasAuthorship W2022145079A5010289974 @default.
• W2022145079 hasAuthorship W2022145079A5038178209 @default.
• W2022145079 hasAuthorship W2022145079A5038955775 @default.
• W2022145079 hasAuthorship W2022145079A5044093768 @default.
• W2022145079 hasAuthorship W2022145079A5044301848 @default.
• W2022145079 hasAuthorship W2022145079A5048965051 @default.
• W2022145079 hasAuthorship W2022145079A5063519178 @default.
• W2022145079 hasBestOaLocation W20221450791 @default.
• W2022145079 hasConcept C121608353 @default.
• W2022145079 hasConcept C126322002 @default.
• W2022145079 hasConcept C190283241 @default.
• W2022145079 hasConcept C2776067312 @default.
• W2022145079 hasConcept C2777176818 @default.
• W2022145079 hasConcept C502942594 @default.
• W2022145079 hasConcept C530470458 @default.
• W2022145079 hasConcept C55493867 @default.
• W2022145079 hasConcept C555283112 @default.
• W2022145079 hasConcept C71924100 @default.

• next